SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-23-021909
Filing Date
2023-03-31
Accepted
2023-03-31 17:47:57
Documents
1
Period of Report
2023-03-29

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4410
  Complete submission text file 0001209191-23-021909.txt   5923
Mailing Address C/O PRESBIA PLC 120/121 BAGGOT STREET LOWER DUBLIN 2 L2 00000
Business Address
Auffarth Gerd (Reporting) CIK: 0001649867 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37759 | Film No.: 23789482

Mailing Address 485 ROUTE 1 SOUTH BUILDING F, SUITE 320 ISELIN NJ 08830
Business Address 485 ROUTE 1 SOUTH BUILDING F, SUITE 320 ISELIN NJ 08830 6096193990
Outlook Therapeutics, Inc. (Issuer) CIK: 0001649989 (see all company filings)

IRS No.: 383982704 | State of Incorp.: DE | Fiscal Year End: 0930
SIC: 2836 Biological Products, (No Diagnostic Substances)